Cargando…

Lower Circulating Leptin Levels Are Related to Non-Alcoholic Fatty Liver Disease in Children With Obesity

BACKGROUND: While for individuals with obesity an association between hyperleptinemia and an increased risk of non-alcoholic fatty liver disease (NAFLD) is assumed, a leptin deficiency is also related to the development of NAFLD early in life in ob/ob mice, in patients with leptin deficiency due to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brandt, Stephanie, von Schnurbein, Julia, Denzer, Christian, Kratzer, Wolfgang, Wabitsch, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169562/ https://www.ncbi.nlm.nih.gov/pubmed/35677722 http://dx.doi.org/10.3389/fendo.2022.881982

Ejemplares similares

Diagnostic and therapeutic odyssey of two patients with compound heterozygous leptin receptor deficiency
por: Zorn, Stefanie, et al.
Publicado: (2020)

Serum IGF1 and linear growth in children with congenital leptin deficiency before and after leptin substitution
por: Beghini, Marianna, et al.
Publicado: (2021)

Severe Early-Onset Obesity Due to Bioinactive Leptin Caused by a p.N103K Mutation in the Leptin Gene
por: Wabitsch, Martin, et al.
Publicado: (2015)

A fresh look to the phenotype in mono-allelic likely pathogenic variants of the leptin and the leptin receptor gene
por: Koerber-Rosso, Ingrid, et al.
Publicado: (2021)

Monogenic forms of childhood obesity due to mutations in the leptin gene
por: Funcke, Jan-Bernd, et al.
Publicado: (2014)

Functional and Phenotypic Characteristics of Human Leptin Receptor Mutations
por: Nunziata, Adriana, et al.
Publicado: (2018)

Measurement of immunofunctional leptin to detect and monitor patients with functional leptin deficiency
por: Wabitsch, Martin, et al.
Publicado: (2016)

Thyroid Function and the Risk of Non-Alcoholic Fatty Liver Disease in Morbid Obesity
por: Borges-Canha, Marta, et al.
Publicado: (2020)

Long-Term Stabilization Effects of Leptin on Brain Functions in a Leptin-Deficient Patient
por: Frank, Sabine, et al.
Publicado: (2013)

Lipodystrophy as a Late Effect after Stem Cell Transplantation
por: Tews, Daniel, et al.
Publicado: (2021)

Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets
por: Chen, Yinshuang, et al.
Publicado: (2023)

First Account of Psychological Changes Perceived by a Female with Congenital Leptin Deficiency upon Treatment with Metreleptin
por: Hebebrand, Johannes, et al.
Publicado: (2022)

SAT-088 A Novel Mutation In The Leptin Receptor Associated With Hypertriglyceridemia, Lipodystrophy And Non-alcoholic Fatty Liver
por: Viana, Gracia, et al.
Publicado: (2019)

Non-Alcoholic Fatty Liver Disease in Obese Youth With Insulin Resistance and Type 2 Diabetes
por: Scapaticci, Serena, et al.
Publicado: (2021)

Clinical features and metabolic complications for non-alcoholic fatty liver disease (NAFLD) in youth with obesity
por: Barbieri, Emiliano, et al.
Publicado: (2023)

Atrial natriuretic peptide and leptin interactions in healthy men
por: Daniels, Martin A., et al.
Publicado: (2023)

Metabolomics reveals an entanglement of fasting leptin concentrations with fatty acid oxidation and gluconeogenesis in healthy children
por: Kirchberg, Franca Fabiana, et al.
Publicado: (2017)

Endotoxins and Non-Alcoholic Fatty Liver Disease
por: Kessoku, Takaomi, et al.
Publicado: (2021)

Leptin and Obesity: Role and Clinical Implication
por: Obradovic, Milan, et al.
Publicado: (2021)

Connection of Nicotine to Diet-Induced Obesity and Non-Alcoholic Fatty Liver Disease: Cellular and Mechanistic Insights
por: Sinha-Hikim, Amiya P., et al.
Publicado: (2017)

Gut Dysfunction and Non-alcoholic Fatty Liver Disease
por: Grabherr, Felix, et al.
Publicado: (2019)

Editorial: Leptin, obesity and diet at a glance
por: Hryciw, Deanne H., et al.
Publicado: (2022)

Editorial: Obesity, Smoking, and Fatty Liver Disease
por: Sinha-Hikim, Amiya P., et al.
Publicado: (2018)

Chronic Oxytocin Administration as a Treatment Against Impaired Leptin Signaling or Leptin Resistance in Obesity
por: Altirriba, Jordi, et al.
Publicado: (2015)

Association between the atherogenic index of plasma and new-onset non-alcoholic fatty liver disease in non-obese participants
por: Li, Kemin, et al.
Publicado: (2022)

Analysis of risk factors for non-alcoholic fatty liver disease in hospitalized children with obesity before the late puberty stage
por: Zhou, Lishan, et al.
Publicado: (2023)

Subclinical and clinical hypothyroidism and non-alcoholic fatty liver disease: a cross-sectional study of a random population sample aged 18 to 65 years
por: Ludwig, Ulla, et al.
Publicado: (2015)

Preoperative circulating peroxiredoxin 1 levels as a predictor of non-alcoholic fatty liver disease remission after laparoscopic bariatric surgery
por: Cheng, Xiaoyun, et al.
Publicado: (2022)

Oxidation-Specific Epitopes in Non-Alcoholic Fatty Liver Disease
por: Hendrikx, Tim, et al.
Publicado: (2020)

Determinants of hyperglucagonemia in pediatric non-alcoholic fatty liver disease
por: Maruszczak, Katharina, et al.
Publicado: (2022)

Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)
por: Rong, Li, et al.
Publicado: (2023)

Role of Leptin in Non-Alcoholic Fatty Liver Disease
por: Jiménez-Cortegana, Carlos, et al.
Publicado: (2021)

New Pharmacological Perspectives for the Leptin Receptor in the Treatment of Obesity
por: Roujeau, Clara, et al.
Publicado: (2014)

Sparse System Identification of Leptin Dynamics in Women With Obesity
por: Amin, Md. Rafiul, et al.
Publicado: (2022)

Loss of Hepatic CEACAM1: A Unifying Mechanism Linking Insulin Resistance to Obesity and Non-Alcoholic Fatty Liver Disease
por: Heinrich, Garrett, et al.
Publicado: (2017)

When Leptin Is Not There: A Review of What Nonsyndromic Monogenic Obesity Cases Tell Us and the Benefits of Exogenous Leptin
por: Salum, Kaio Cezar Rodrigues, et al.
Publicado: (2021)

Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD)
por: Cuthbertson, Daniel J., et al.
Publicado: (2021)

The Role of Lipophagy in the Development and Treatment of Non-Alcoholic Fatty Liver Disease
por: Grefhorst, Aldo, et al.
Publicado: (2021)

Autonomic Imbalance Increases the Risk for Non-alcoholic Fatty Liver Disease
por: Jung, Inha, et al.
Publicado: (2021)

Leptin Does Not Influence TSH Levels in Obese Short Children
por: Adamczewska, Katarzyna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m7lh5vqsckj432t62p6hpne9e5